A detailed history of High Tower Trust Services, Lta transactions in Novo Nordisk A S stock. As of the latest transaction made, High Tower Trust Services, Lta holds 86,228 shares of NVO stock, worth $8.77 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
86,228
Previous 86,228 -0.0%
Holding current value
$8.77 Million
Previous $11.7 Million 17.59%
% of portfolio
1.28%
Previous 1.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

SELL
$102.55 - $135.33 $135,058 - $178,229
-1,317 Reduced 1.5%
86,228 $11.7 Million
Q3 2022

Oct 07, 2022

BUY
$95.28 - $116.93 $6.38 Million - $7.83 Million
66,988 Added 325.86%
87,545 $8.72 Million
Q2 2022

Jul 22, 2022

SELL
$103.24 - $121.81 $1.64 Million - $1.93 Million
-15,859 Reduced 43.55%
20,557 $732,000
Q1 2022

Apr 21, 2022

BUY
$93.1 - $112.54 $12,568 - $15,192
135 Added 0.37%
36,416 $4.04 Million
Q4 2021

Jan 14, 2022

SELL
$95.88 - $117.08 $8,629 - $10,537
-90 Reduced 0.25%
36,281 $4.06 Million
Q3 2021

Oct 26, 2021

BUY
$84.42 - $106.62 $84 - $106
1 Added 0.0%
36,371 $3.49 Million
Q2 2021

Aug 02, 2021

SELL
$67.66 - $84.76 $3,518 - $4,407
-52 Reduced 0.14%
36,370 $3.05 Million
Q1 2021

May 03, 2021

BUY
$67.06 - $75.82 $13,277 - $15,012
198 Added 0.55%
36,422 $2.46 Million
Q4 2020

Jan 29, 2021

SELL
$63.89 - $73.8 $13,097 - $15,129
-205 Reduced 0.56%
36,224 $2.53 Million
Q3 2020

Oct 19, 2020

BUY
$63.69 - $70.22 $66,874 - $73,731
1,050 Added 2.97%
36,429 $2.53 Million
Q2 2020

Jul 17, 2020

BUY
$58.54 - $67.94 $3,629 - $4,212
62 Added 0.18%
35,379 $2.32 Million
Q3 2019

Oct 23, 2019

BUY
$47.54 - $53.43 $6,322 - $7,106
133 Added 0.38%
35,317 $1.83 Million
Q2 2019

Jul 29, 2019

BUY
$46.79 - $52.47 $1.65 Million - $1.85 Million
35,184 New
35,184 $1.8 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track High Tower Trust Services, Lta Portfolio

Follow High Tower Trust Services, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Trust Services, Lta, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Trust Services, Lta with notifications on news.